Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

The Discovery of Novel Small Molecule Inhibitors of Bacterial Ribosome Biogenesis

FY 2011-12

Summary
Over the past 40 years, only two new classes of antibiotics have been introduced into the clinic to be administered to humans. Compounding this problem is the fact that current antibiotics act on a small number of targets, namely cell wall synthesis, DNA synthesis, and protein synthesis. With an aging selection of antibiotics targeting such a narrow range of cellular processes, it is not surprising that antibiotic-resistant pathogenic bacteria are frequently found in clinical and non-clinical settings. Because of the severe impact that antibiotic-resistant bacteria place on individuals and healthcare systems as a whole, it is essential that researchers continue to search for new antibiotics until they are discovered, characterized, and used to cure infections successfully in a clinical setting. The project that I have been working on for the past 15 months is aimed at discovering new antibiotics using a relatively new technique known as high-throughput screening. What makes this project particularly exciting is that it has been specifically designed to find new molecules against a cellular process that has never been targeted by previous antibiotics. The cellular process that I am interested in preventing is called ribosome biogenesis, which is the process by which ribosomes (the cellular machines that make proteins) are assembled within bacteria. Decades of previous research have shown that bacteria that are unable to efficiently assemble ribosomes either grow extremely poorly, or do not grow at all. So far in my project, I have discovered 40 molecules that I believe all inhibit ribosome biogenesis, and I am currently in the process of determining their exact mechanism of action within cells. The discovery of new molecules that inhibit ribosome biogenesis is the first step in developing novel antibiotics to successfully treat antibiotic-resistant bacterial infections.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
253335
Name
Stokes Jonathan M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The Discovery of Novel Small Molecule Inhibitors of Bacterial Ribosome Biogenesis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Analytical Centrifugation; Antibiotics; Bacterial Physiology; Chemical Biology; Drug Discovery; High-Throughput Screening; Infectious Disease; Microscopy; Molecular Genetics; Ribosome Biogenesis
Abstract
Over the past 40 years, only two new classes of antibiotics have been introduced into the clinic to be administered to humans. Compounding this problem is the fact that current antibiotics act on a small number of targets, namely cell wall synthesis, DNA synthesis, and protein synthesis. With an aging selection of antibiotics targeting such a narrow range of cellular processes, it is not surprising that antibiotic-resistant pathogenic bacteria are frequently found in clinical and non-clinical settings. Because of the severe impact that antibiotic-resistant bacteria place on individuals and healthcare systems as a whole, it is essential that researchers continue to search for new antibiotics until they are discovered, characterized, and used to cure infections successfully in a clinical setting. The project that I have been working on for the past 15 months is aimed at discovering new antibiotics using a relatively new technique known as high-throughput screening. What makes this project particularly exciting is that it has been specifically designed to find new molecules against a cellular process that has never been targeted by previous antibiotics. The cellular process that I am interested in preventing is called ribosome biogenesis, which is the process by which ribosomes (the cellular machines that make proteins) are assembled within bacteria. Decades of previous research have shown that bacteria that are unable to efficiently assemble ribosomes either grow extremely poorly, or do not grow at all. So far in my project, I have discovered 40 molecules that I believe all inhibit ribosome biogenesis, and I am currently in the process of determining their exact mechanism of action within cells. The discovery of new molecules that inhibit ribosome biogenesis is the first step in developing novel antibiotics to successfully treat antibiotic-resistant bacterial infections.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stokes, Jonathan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~